Adverse drug reactions in the oral cavity
Adverse drug reactions commonly occur in the oral cavity, and although these reactions are seldom life threatening, they may severely affect quality of life, as well as the nutritional status of the patient. Hyposalivation is often caused by antidepressants, antihistamines, and diuretics, and the risk increases with polypharmacy. A dry mouth may in turn lead to oral candidosis, which may also be caused by treatment with antibiotics, immunosuppressants or corticosteroids. Other possible adverse drug reactions that may be seen in the oral cavity include gingival hyperplasia, ulcerations, allergic mucosal reactions, changes in sensibility or taste, as well as discoloration of saliva and/or the oral mucosa. Drug-induced osteonecrosis of the jaw from bisphosphonates is also mentioned in this context. The risk of many adverse drug reactions in the mouth can be decreased by good oral hygiene, in combination with regular revisions of the patient's drug treatment. However, there is a risk that physicians do not examine the oral cavity, while dentists may not have complete information about the patient's drug treatment. A close collaboration between medical and dental health care is the key to reducing adverse drug reactions in the mouth.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:121 |
---|---|
Enthalten in: |
Lakartidningen - 121(2024) vom: 12. März |
Sprache: |
Schwedisch |
---|
Weiterer Titel: |
Läkemedelsbiverkningar som kan uppkomma i munhålan |
---|
Beteiligte Personen: |
Böttiger, Ylva [VerfasserIn] |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 13.03.2024 Date Revised 04.04.2024 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM369600029 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369600029 | ||
003 | DE-627 | ||
005 | 20240404235009.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240312s2024 xx |||||o 00| ||swe c | ||
028 | 5 | 2 | |a pubmed24n1364.xml |
035 | |a (DE-627)NLM369600029 | ||
035 | |a (NLM)38470273 | ||
035 | |a (PII)23205 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a swe | ||
100 | 1 | |a Böttiger, Ylva |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adverse drug reactions in the oral cavity |
246 | 3 | 3 | |a Läkemedelsbiverkningar som kan uppkomma i munhålan |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.03.2024 | ||
500 | |a Date Revised 04.04.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Adverse drug reactions commonly occur in the oral cavity, and although these reactions are seldom life threatening, they may severely affect quality of life, as well as the nutritional status of the patient. Hyposalivation is often caused by antidepressants, antihistamines, and diuretics, and the risk increases with polypharmacy. A dry mouth may in turn lead to oral candidosis, which may also be caused by treatment with antibiotics, immunosuppressants or corticosteroids. Other possible adverse drug reactions that may be seen in the oral cavity include gingival hyperplasia, ulcerations, allergic mucosal reactions, changes in sensibility or taste, as well as discoloration of saliva and/or the oral mucosa. Drug-induced osteonecrosis of the jaw from bisphosphonates is also mentioned in this context. The risk of many adverse drug reactions in the mouth can be decreased by good oral hygiene, in combination with regular revisions of the patient's drug treatment. However, there is a risk that physicians do not examine the oral cavity, while dentists may not have complete information about the patient's drug treatment. A close collaboration between medical and dental health care is the key to reducing adverse drug reactions in the mouth | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Diphosphonates |2 NLM | |
700 | 1 | |a Ekenstråle, Emma |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Lakartidningen |d 1965 |g 121(2024) vom: 12. März |w (DE-627)NLM000007544 |x 1652-7518 |7 nnns |
773 | 1 | 8 | |g volume:121 |g year:2024 |g day:12 |g month:03 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 121 |j 2024 |b 12 |c 03 |